Articles

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

Percutaneous transluminal coronary angioplasty (PTCA) balloon catheters were the first devices used in the field of interventional cardiology. The growth of the stent market, which is the largest...

AngioScore AngioSculpt Drug-Coated Scoring Catheter FIH Study

AngioScore Inc. announced the completion of enrollment in the Drug-Coated AngioSculpt Scoring Balloon Catheter First-in-Human (FIH) Study (PATENT-C). AngioScore anticipates that preliminary data...

Boston Scientific, Apex, balloon catheter

The total U.S. market for PTCA and cutting balloon catheters was valued at $293.5 million in 2012. The PTCA balloon segment accounted for close to 90 percent of the total coronary balloon catheter...

balloon, CTO

Physicians have new tools for treating chronic total occlusions (CTOs) after Abbott received U.S. Food and Drug Administration (FDA) approval for guidewires and balloon dilation catheters for...

C-section Hysterectomy Clinical trial Interventional Radiology Balloon Catheter

Using tiny balloons to temporarily block blood flow to the uterus during a high-risk Caesarean-section delivery can save the life of the mother while preventing hysterectomy and preserving...

Several paclitaxel drug-eluting balloons (DEBs) are currently available on the European market, and several others are in development. There are currently no DEBs available in the United States....

Drug-eluting balloons (DEBs) may offer new options in treating peripheral vessels and restenosis. DEBs already offer an alternative treatment tool in Europe, and the first DEB clinical trial in...

In recent years, many medical device companies saw the underserved lower extremity as an opportunity to enter the market for peripheral artery disease (PAD) treatments. For this reason, device...

The focus on balloon angioplasty largely slipped from the interventional limelight a decade ago after the introduction of stents, but today there is some renewed interest with the advent of new...